Author

J. L. Bubenik

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

M. Swanson· 2 shared A. Chopra· 1 shared A. H. Elsayed· 1 shared A. J. Keeley· 1 shared A. J. Winer· 1 shared A. Meacham· 1 shared A. Riva· 1 shared A. Sette· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

M. Swanson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Heterogeneous Nuclear Ribonucleoprotein C is an Indispensable Target in Acute Myeloid Leukemia

V. Vijay, A. Meacham, L. M. Katzell, A. J. Winer, J. Terrell, V. L. Archibald, L. T. Vaughn, L. Drusbosky, E. Thach, G. Welmaker, M. Giulianotti, S. Brothers, E. Beurel, J. L. Bubenik, M. Swanson, , C. R. Cogle

This study identifies HNRNPC as a critical therapeutic target in AML by showing its role in regulating Myc-Max activity through alternative splicing.

bioRxiv · Oct 2, 2023 · PreprintCancer Biology

Generation of a novel SARS-CoV-2 sub-genomic RNA due to the R203K/G204R variant in nucleocapsid: homologous recombination has potential to change SARS-CoV-2 at both protein and RNA level

S. Leary, S. Gaudieri, M. D. Parker, A. Chopra, I. James, S. Pakala, E. Alves, M. John, B. B. Lindsey, A. J. Keeley, S. L. Rowland-Jones, M. Swanson, D. A. Ostrov, J. L. Bubenik, S. Das, , S. Mallal

The paper identifies a novel SARS-CoV-2 sub-genomic RNA generated by homologous recombination involving the R203K/G204R variant in nucleocapsid, which may enhance viral adaptation and expression.

bioRxiv · Apr 10, 2020 · PreprintMicrobiology